These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1651161)

  • 21. [Lipoprotein Lp(a): a new risk factor of atherogenesis].
    Davidoff P; Bruckert E; Giral P; Doumith R; Thervet F; Truffert J; de Gennes JL
    Diabete Metab; 1989; 15(2):55-60. PubMed ID: 2525490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lowering of lipoprotein(a) level under niacin treatment is dependent on apolipoprotein(a) phenotype.
    Artemeva NV; Safarova MS; Ezhov MV; Afanasieva OI; Dmitrieva OA; Pokrovsky SN
    Atheroscler Suppl; 2015 May; 18():53-8. PubMed ID: 25936305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prospective trends in studies on the role of lipoproteins in human atherogenesis: their effect on disease progression, diagnostic value and the possibility of corrective interventions].
    Perova NV
    Kardiologiia; 1989 Jun; 29(6):5-9. PubMed ID: 2779078
    [No Abstract]   [Full Text] [Related]  

  • 24. Disturbances in dietary fat metabolism and their role in the development of atherosclerosis.
    Weintraub M; Charach G; Grosskopf I
    Biomed Pharmacother; 1997; 51(8):311-3. PubMed ID: 9436521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent developments in atherogenesis.
    Stein O; Stein Y
    Arzneimittelforschung; 1990 Mar; 40(3A):348-50. PubMed ID: 2185761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of lipid-lowering agents.
    Sirtori CR; Manzoni C; Lovati MR
    Cardiology; 1991; 78(3):226-35. PubMed ID: 1868500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xanthomas and hyperlipidemias.
    Parker F
    J Am Acad Dermatol; 1985 Jul; 13(1):1-30. PubMed ID: 4031142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lipoprotein(a): risk factor for atherosclerotic vascular disease important to take into account in practice].
    Couderc R; Maachi M
    Ann Biol Clin (Paris); 1999; 57(2):157-67. PubMed ID: 10210742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects.
    Schmitz G; Orsó E
    Clin Res Cardiol Suppl; 2015 Apr; 10(Suppl 1):21-5. PubMed ID: 25708587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein metabolism by rat hepatomas. Studies on the etiology of defective dietary feedback inhibition of cholesterol synthesis.
    Barnard GF; Erickson SK; Cooper AD
    J Clin Invest; 1984 Jul; 74(1):173-84. PubMed ID: 6330173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein (a): perspectives from a lipid-referral program.
    Rubenfire M; Vodnala D; Krishnan SM; Bard RL; Jackson EA; Giacherio D; Brook RD
    J Clin Lipidol; 2012; 6(1):66-73. PubMed ID: 22264576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current approaches to the diagnosis and correction of atherogenic dyslipoproteinemia].
    Oganov RG; Perova NV
    Kardiologiia; 1989 Oct; 29(10):15-22. PubMed ID: 2615152
    [No Abstract]   [Full Text] [Related]  

  • 33. [Gene polymorphisms in atherosclerotic diseases and lipoprotein metabolism disorders].
    Yokode M
    Nihon Ronen Igakkai Zasshi; 1999 Apr; 36(4):238-41. PubMed ID: 10410565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a).
    Grützmacher P; Öhm B; Szymczak S; Dorbath C; Brzoska M; Kleinert C
    Clin Res Cardiol Suppl; 2017 Mar; 12(Suppl 1):22-26. PubMed ID: 28233269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update on the hyperlipidemias and atherosclerosis.
    Powell RC
    Indiana Med; 1984 Jun; 77(6):441-5. PubMed ID: 6736617
    [No Abstract]   [Full Text] [Related]  

  • 36. Hyperlipoproteinemia(a): clinical significance and treatment options.
    Berthold HK; Gouni-Berthold I
    Atheroscler Suppl; 2013 Jan; 14(1):1-5. PubMed ID: 23357133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein(a) as candidate genes of premature development of atherosclerosis.
    Horejsí B; Ceska R
    Physiol Res; 2000; 49 Suppl 1():S63-9. PubMed ID: 10984073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of atherosclerosis.
    Moore S
    Metabolism; 1985 Dec; 34(12 Suppl 1):13-6. PubMed ID: 3906356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of dependence of lipoprotein(a) on triglyceride and high-density lipoprotein metabolism.
    Konerman M; Kulkarni K; Toth PP; Jones SR
    J Clin Lipidol; 2012; 6(1):27-32. PubMed ID: 22264571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperlipoproteinemia in chronic renal failure: pathophysiological and therapeutic aspects.
    Wanner C; Frommherz K; Hörl WH
    Cardiology; 1991; 78(3):202-17. PubMed ID: 1868498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.